Less frequent glatiramer acetate (Copaxone)

A study presented at AAN found that people taking a double dose of Copaxone three times a week showed a reduction in the relapse rate of about a third compared to placebo. Although not studied against the daily dose, the effects are similar. Results presented at the AAN (American Academy of Neurology) meeting. Internal Medicine News Glatiramer acetate (Copaxone) - A to Z of MS
Source: Multiple Sclerosis Trust - Category: Neurology Source Type: news